Toshifumi Tada, Medicago CEO
October 27, 2022 11:45 AM EDTUpdated 01:10 PM
People
R&D

Plant-based Covid-19 vac­cine de­vel­op­er Med­ica­go lay­ing off 60+ at North Car­oli­na plant

Paul Schloesser

Associate Editor

Med­ica­go had been look­ing at, among oth­er things, a plant-based vac­cine for Covid-19. But those plans aren’t go­ing in the di­rec­tion Med­ica­go want­ed to. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J takes 340B fight with fed­er­al gov­ern­ment to court

Dan­ish biotech Gubra touts ear­ly weight loss da­ta in hot amylin field

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

Ex­clu­sive: Flag­ship names two CEO-part­ners to lead Va­lo Health, Apri­ori Bio

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times